首页> 外文期刊>BioMed research international >Surgical Results of Retrograde Mastoidectomy with Primary Reconstruction of the Ear Canal and Mastoid Cavity
【24h】

Surgical Results of Retrograde Mastoidectomy with Primary Reconstruction of the Ear Canal and Mastoid Cavity

机译:逆行乳腺切除术与初级重建耳道和乳突腔的外科结果

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to retrospectively review the long-term hearing results and the impact of mastoid exclusion/obliteration in patients with cholesteatoma (102 ears) who underwent retrograde tympanomastoidectomy and in whom bone chips/pate were applied as the sole materials during the procedure. In 79 ears, this was combined with ossiculoplasty in a single-stage procedure. In >71% of ears, the results of audiometric testing were monitored for more than 2 years. The results suggested there was a significant gain in hearing following surgery, with respect to the postoperative change in both air-conduction thresholds and air-bone gaps (P < 0.001). Linear regression analyses of pure-tone averages at different frequencies, before and after surgery, demonstrated that patients benefitted from a postoperative hearing gain at low and middle frequencies, but their hearing often deteriorated at frequencies of 8000 Hz. As for the impact of the type of tympanoplasty on hearing outcomes, type Ill-interposition markedly increased hearing gain. The overall rate of postoperative adverse events was 8.8%. We conclude that reconstruction of the ear canal and mastoid via mastoid exclusion/obliteration using bone chips/pate can be considered as an alternative procedure following retrograde mastoidectomy. It gives excellent surgical results and has fewer postoperative adverse events.
机译:本研究的目的是回顾性地审查长期听力结果和乳突爆炸/灭菌患者对胆囊瘤(102只耳朵)的乳突排斥/灭菌的影响,他们在逆行鼓膜瘤孢子切除术和骨芯片/头脑被施加为唯一材料期间程序。在79个耳朵中,在单级程序中,这与Ossiculoplasty相结合。在> 71%的耳朵中,监测听力测试的结果超过2年。结果表明,在手术后在手术后有显着的增益,相对于空气传导阈值和空气骨间隙的术后变化(P <0.001)。不同频率,手术前后的纯音均衡的线性回归分析证明患者受益于低和中频的术后听力增益,但它们的听力经常在8000 Hz的频率下恶化。至于对鼓室成形术类型对听力结果的影响,型号interposition显着增加了听力增益。术后不良事件的总体率为8.8%。我们得出结论,通过使用骨芯片/包装的乳突排阻/灭菌来重建耳腔管和乳突,可以被认为是逆行乳腺切除术后的替代程序。它提供了出色的外科结果,术后不良事件较少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号